ADILA was presented at ESCMID Global 2024!

Conference Abstracts

Development and Evaluation of a novel prevalence survey method in primary care (APC-PPS)
Current global total and AWaRe global antibiotic use are inversely related to infectious disease burden and not equitable
Does antibiotic formulation provide reasonable estimates of antibiotic use across different sectors?
Global costing of key AWaRe antibiotics
Antibiotic prescribing for common infections and association with patient outcomes: analysis using electronic prescription data in Vietnam primary care centres
Consumption and regulatory status of pros AWaRe antibiotics not included in the WHO Essential Medicines List: the Great Group
Lack of Agreement of 80 National Standard Treatment Guidelines with WHO AWaRe Antibiotic Book recommendations
Deriving a novel method to calculate AMU for policy interventions for antibiotics without a WHO DD
Observed vs expected levels of empirical antibiotics usage based on the WHO AWaRe antibiotic book: a new benchmarking tool
Deriving ‘fair levels’ of total and AWaRe antibiotic use, adjusted for clinical burden at a national-level, to inform future target setting
IV antibiotics in hospital settings can be used with caution to represent national parenteral AWaRe antibiotic procurement rate; and 95% of national oral Access and Watch antibiotic can be assumed with caution as being used in primary care settings
Development and evaluation of a novel antibiotic point prevalence survey method in primary healthcare (APC-PPS study)
Global Pricing of Key AWaRe Antibiotics
Antibiotic prescribing for common infections and association with patient outcomes: analysis using electronic prescription data in Vietnam primary care centres
A new benchmarking tool: antibiotic usage in hospitals based on the levels of empirical OBSERVED vs EXPECTED WHO A Re book
Deriving ‘fair levels’ of total and AWaRe antibiotic use, adjusted for clinical burden at a national-level, to inform future target setting

12:00 – Poster Area – Poster Session

5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)

P2646 – Lack of agreement of 80 national standard treatment guidelines with WHO AWaRe antibiotic book recommendations
Shrey Mathur

P2664 – Development and evaluation of a novel antibiotic point prevalence survey method in primary care (APC-PPS)
Aislinn Cook

5f. Pharmacoepidemiology / pharmacoeconomics (incl cost-effectiveness, modelling, data tools)

P2739 – Antibiotic prescribing for common infections and association with patient outcomes: analysis using electronic prescription data in Vietnam primary care centres
Nam Nguyen

16:15 – Arena 3

Exploring the social dimensions of antimicrobial resistance

ePoster flash Session – Deriving “fair levels” of total and AWaRe antibiotic use, adjusted for clinical burden at a national-level, to inform future target setting
Aislinn Cook

17:30 in Hall D

Digital solutions for surveillance

Oral Session – Deriving a novel method to calculate AMU for policy interventions for antibiotics without a WHO DDD
Mike Thorn 

Monday 29 April 2024

12:00 in Poster Area – Poster Session

3h. Policy aspects of AMR (incl societal impact, economics, mitigation)

P1913 – Current global total and AWaRe global antibiotic use are inversely related to infectious disease burden and not equitable.
Aislinn Cook

P1909 – Global costing of key AWaRe antibiotics
Filip Djukic

13:30 – Arena 3

Antimicrobial stewardship around the world

ePoster flash Session – Observed vs expected levels of empirical antibiotic usage based on the WHO AWaRe antibiotic book: a new benchmarking tool
Myo Swe

ePoster flash Session – Consumption and regulatory status of oral AWaRe antibiotics not included in the WHO essential medicines list: the Grey Group
Shrey Mathur 

Tuesday 30 April 2024

11:00 – Arena 3

What’s in my antimicrobial stewardship toolbox?

ePoster flash Session – Does antibiotic formulation provide reasonable estimates of antibiotic use across different sectors?
Cherry Lim